
4C Medical Secures $175M
Summary 4C Medical Technologies secured $175 million in Series D funding, led by Boston Scientific, to advance its transcatheter mitral valve replacement (TMVR) technology. The funding will support the ongoing ATLAS global pivotal trial, evaluating […]